The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
4 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $757,582 in first-year total cost, median $191,299.
Most frequent study sections
- Special Emphasis Panel[ZDA1 JXR-G (10)]4
Most frequent institutions
- ABZYME THERAPEUTICS, LLC1
- ACTIVE MOTIF, INC.1
- MEDIOMICS, LLC1
- VISTERRA, INC.1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2016 | Multi-epitope tag (MET)-recombinant antibody toolbox for detection and manipulation of RNA modifications1R43DA042463-01 | CARPENTER, LAURA ROCCOKELLY, THERESA K. | ACTIVE MOTIF, INC., CA | $224,995 | ZDA1 |
| 2016 | Novel approach for rapid generation of human antibodies to RNA-modifications1R43DA042461-01 | SWOBODA, ROLF K | ABZYME THERAPEUTICS, LLC, PA | $224,638 | ZDA1 |
| 2016 | Development of Recombinant Antibodies for Detection of RNA Modifications at Single Nucleotide Resolution1R43DA042468-01 | TIAN, LING | MEDIOMICS, LLC, MO | $157,959 | ZDA1 |
| 2016 | A Library of Immunoaffinity Reagents for RNA modifications1R43DA042466-01 | DEDON, PETER CSHRIVER, ZACHARY H | VISTERRA, INC., MA | $149,990 | ZDA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.